Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma

30 Sept 2022

Abstract excerpt

Lung adenocarcinoma (LUAD) is the most prevalent subtype of non-small cell lung cancer (NSCLC) and is associated with high mortality rates. However, effective methods to guide clinical therapeutic strategies for LUAD are still lacking. The goals of this study were to analyze the relationship between an m5C/m6A-related signature and LUAD and construct a novel model for evaluating prognosis and predicting drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related gene regulation
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36246622
DOI: 10.3389/fgene.2022.990623

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinomaPMID 36246622Read ↗

Identification of Molecular Subtypes and a Prognostic Signature Based on m6A/m5C/m1A-Related Genes in Lung adenocarcinomaSemantic proximity Read ↗

Construction of an m6A-related lncRNA model for predicting prognosis and immunotherapy in patients with lung adenocarcinomaSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Characteristic of Classification and Prognostic Scoring Based on M6a RNA Methylation Modification in Lung Adenocarcinoma and Tumor Microenvironment AssociationSemantic proximity Read ↗

Deciphering N6‐Methyladenosine‐Related Genes Signature to Predict Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of the Signature Associated With m6A RNA Methylation Regulators and m6A-related Genes and Construction of the Risk Score for Prognostication in Early-stage Lung AdenocarcinomaSemantic proximity Read ↗

Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genesSemantic proximity Read ↗

M6a Regulator-Mediated RNA Methylation modification Patterns Correlated With Prognosis Value and Immune Response in Adenocarcinoma of lungSemantic proximity Read ↗

Identification of the Signature Associated With m6A RNA Methylation Regulators and m6A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung AdenocarcinomaSemantic proximity Read ↗

Identification of the Signature Associated with m6A RNA Methylation Regulators and m6A-Related Genes and Construction of the Risk Score for Prognostication in Early-Stage Lung AdenocarcinomaSemantic proximity Read ↗

Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.